5 results
This new developed knee prosthesis will be compared to the standard scorpio PS knee prosthesis. In this comparison it will be examined ifthe changes in design really do improve function and deminish pain. Allso patella tracking and patella tilting…
This new developed knee prosthesis will be compared to the standard scorpio PS knee prosthesis. In this comparison it will be examined if the changes in design really do improve function and deminish pain. Allso patella tracking and patella tilting…
To determine the therapeutic effect of contralesional cTBS on recovery of function of the paretic arm, at 3 months after ischemic stroke
ALZ-801 is an oral agent that is being developed as a potential disease modifying treatment for AD. This 78-week Phase 3 study will focus on Early AD subjects who carry the APOE4/4 genotype, and is designed according to current regulatory guidance…
Objectives - Core StudyPrimary Objectives• To evaluate the effects of oral ALZ-801 in subjects with Early AD who have the APOE4/4 or APOE3/4 genotype, on the plasma biomarkers of core AD pathology and brain volumes* Primary Plasma Biomarker Outcome…